1. Home
  2. CRCT vs SLS Comparison

CRCT vs SLS Comparison

Compare CRCT & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$4.24

Market Cap

857.6M

Sector

Industrials

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$4.85

Market Cap

706.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
SLS
Founded
1969
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
857.6M
706.7M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
CRCT
SLS
Price
$4.24
$4.85
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
2
1
Target Price
$3.50
$10.00
AVG Volume (30 Days)
484.4K
5.9M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
22.25%
N/A
EPS Growth
20.69
50.00
EPS
0.35
N/A
Revenue
$708,780,000.00
N/A
Revenue This Year
$0.08
N/A
Revenue Next Year
$0.98
$67.40
P/E Ratio
$12.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.74
$1.26
52 Week High
$7.33
$6.14

Technical Indicators

Market Signals
Indicator
CRCT
SLS
Relative Strength Index (RSI) 56.14 52.42
Support Level $4.20 $4.70
Resistance Level $4.26 $5.01
Average True Range (ATR) 0.14 0.33
MACD 0.05 0.02
Stochastic Oscillator 82.40 61.76

Price Performance

Historical Comparison
CRCT
SLS

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: